Nanolek
Verified IntelNanolek is a Russian fast-growing pharmaceutical company which aims to become one of the market leaders in the production of innovative biotechnological products and modern vaccines, stimulating the creation of the national bioeconomy and amplifying the country’s biosafety. Nanolek’s product portfolio is formed in compliance with the priority therapeutic areas: cardiological and oncological products, innovative vaccines, including the cell-based influenza vaccine and the first Russian inactivated polio vaccine. In the meantime the company is also developing a number of biotech products, including new to the Russian market modern vaccines.
Nanolek is a Russian fast-growing pharmaceutical company which aims to become one of the market leaders in the production of innovative biotechnological products and modern vaccines, stimulating the creation of the national bioeconomy and amplifying the country’s biosafety. Nanolek’s product portfolio is formed in compliance with the priority therapeutic areas: cardiological and oncological products, innovative vaccines, including the cell-based influenza vaccine and the first Russian inactivated polio vaccine. In the meantime the company is also developing a number of biotech products, including new to the Russian market modern vaccines.
Corporate Firmographics
Entity classification and operating profile
- Industry
- General
- Company Type
- Privately Held
- Founded
- 2011
- Employee Bracket
- 51-200
- Estimated Revenue Range
- Undisclosed
Geographic Coordinates
Headquarters address and regional territory
- Street Address
- Baker Plaza Business center, offi‡ce 45, Moscow
- City
- —
- Region / State
- —
- Postal Code
- 127055
- Country
- Russia
Digital Presence & Footprint
Verified domains, socials, and directory profiles
Frequently Asked Questions
Verified business inquiries and firmographic telemetry for Nanolek.